Fourth, manufacturing scale and supply chain reliability have emerged as competitive advantages distinct from molecular innovation
TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions
Endocrinology 155, 12801290
Its research application in skin aging derives from its ability to modulate the SNARE complex, which facilitates acetylcholine release at the dermal-muscular interface
If you accidentally add 6 mL, the concentration drops to 4.17 mg/mL, and every dose you draw will be under-dosed by 17%
Drug Development and Industrial Pharmacy, 45(9), 14031420